Showing results (111-120 of 151) with videos related to
Sort By:
Pageof 16
Rheumatology (Oxford, England)|August 23, 2015
Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohortJan H Schirmer, Marvin N Wright, Reinhard Vonthein, et al.Rheumatology (Oxford, England)|April 22, 2026
Current management of eosinophilic granulomatosis with polyangiitis across Europe: insights from a multinational expert surveyEdoardo Conticini, Giacomo Emmi, Silvia Grazzini, et al.Arthritis and Rheumatism|October 29, 2011
Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin trapsNishant Dwivedi, Jagriti Upadhyay, Indira Neeli, et al.Rheumatology (Oxford, England)|October 31, 2003
Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre studyElena Csernok, Julia Holle, Bernhard Hellmich, et al.Annals of the Rheumatic Diseases|December 16, 2006
EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitisBernhard Hellmich, Oliver Flossmann, Wolfgang L Gross, et al.Zeitschrift Fur Rheumatologie|August 7, 2020
[Recommendations of the German Society for Rheumatology for management of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic - Update July 2020]Hendrik Schulze-Koops, Christof Iking-Konert, Jan Leipe, et al.Annals of the Rheumatic Diseases|March 10, 2022
Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trialMaria C Cid, Sebastian H Unizony, Daniel Blockmans, et al.Arthritis & Rheumatology (Hoboken, N.J.)|September 22, 2025
The Effect of Benralizumab and Mepolizumab on Use of Oral Glucocorticoids in Patients With Eosinophilic Granulomatosis With PolyangiitisParameswaran K Nair, Bernhard Hellmich, Arnaud Bourdin, et al.Rheumatology (Oxford, England)|December 5, 2025
Recommendations of the German, Austrian and Swiss rheumatology and other medical societies for the management of polymyalgia rheumaticaFrank Buttgereit, Zhivana Boyadzhieva, Myriam Reisch, et al.Annals of the Rheumatic Diseases|February 24, 2018
Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's diseaseCem Gabay, Bruno Fautrel, Jürgen Rech, et al.Pageof 16